PHARMA JOBS IN AHMEDABAD — TORRENT PHARMA

Fresh­ers Pharma Jobs at  Tor­rent Pharma Ahmedabad

JobTi­tle: MEDICAL REPRESENTATIVE 

About  Tor­rent Pharma   :
The flag­ship com­pany of the Tor­rent Group, Tor­rent Phar­ma­ceu­ti­cals Lim­ited is a major player in the Indian phar­ma­ceu­ti­cals sec­tor with the vision of becom­ing a global entity. Tor­rent Pharma enjoys dom­i­nance in the niche ther­a­peu­tic areas like, car­dio­vas­cu­lar and cen­tral ner­vous sys­tem, gastro-intestinal, pain man­age­ment and oral anti-diabetic seg­ments.
Tor­rent Pharma owes its suc­cess in the domes­tic mar­ket to its thrust on front­line research, strate­gic mar­ket­ing and world-class man­u­fac­tur­ing. It is among the largest spenders on R&D and has set up one of the most advanced research cen­ters in the coun­try at an invest­ment of Rs. 200 crores so far. It has dis­cov­ered and patented the AGE (Advanced Gly­co­sy­la­tion End Prod­uct) Breaker Com­pound which has poten­tial to treat heart dis­eases and dia­betes related vas­cu­lar com­pli­ca­tions. Its man­u­fac­tur­ing facil­i­ties have received qual­ity cer­ti­fi­ca­tions from var­i­ous inter­na­tional reg­u­la­tory author­i­ties.
It is this suc­cess that Tor­rent Pharma attempts to repli­cate in the inter­na­tional mar­ket now. It has already estab­lished fully-owned sub­sidiaries in Aus­tralia , Brazil , Ger­many , Japan , Mex­ico , Philip­pines Rus­sia and USA and has over 1000 prod­uct reg­is­tra­tions in more than 50 coun­tries worldwide

Expe­ri­ence:0 — 5 Years

Skills: Pharma 

Desired:
Can­di­date with Non Sci­ence back­ground ( BCom / BA ) should pos­sess min­i­mum 1 year of expe­ri­ence as Med­ical Representative

Loca­tion: Ahmed­abad

Edu­ca­tion:  Any Grad­u­ate   /  Any PG Course

Click here to Apply: http://jobsearch.naukri.com/mynaukri/mn_newminnernew.php?f=080609000552

Venue:
Tor­rent Phar­ma­ceu­ti­cals Ltd
Tor­rent House
Off.Ashram Road,
Ahmedabad,Gujarat,INDIA 380009

Con­tact Num­ber:91 – 11-079 – 26585090

Web­Site : http://www.torrentpharma.com/

Comments are closed.